Navigation Links
New Clinical Trial - Natreon’s PrimaVie® Shilajit Ingredient Showed Results of Improved Skin Health in Adult Women
Date:7/10/2019

Natreon announces the results of the recently published randomized, double-blind, placebo controlled clinical study from Ohio State University Wexner Medical Center for PrimaVie®, its patented shilajit extract. PrimaVie® is an organic humic substance containing urolithins, fulvic acid, and micro minerals. Natreon is committed to continued scientific investment and research focused on the Beauty-From- Within and skin health categories. This marks the 10th clinical trial published by Natreon for its innovative biome optimized shilajit extract.

The present study aimed to evaluate the effects of oral shilajit supplementation on skin gene expression profile and micro perfusion in healthy adult females. The study design comprised of six total study visits, including the baseline visit (V1), and a final 14-week visit (V6) following shilajit supplementation (125 or 250mg bid). A skin biopsy of the left inner upper arm of each subject was collected at visits 2 and 6 for gene expression profiling using Affymetrix Clariom™ D Assay. Skin perfusion was determined by MATLAB processing of dermascopic images. Transcriptome data were normalized and subjected to statistical analysis. The differentially regulated genes were subjected to Ingenuity Pathway Analysis (IPAV R). The expression of the differentially regulated genes identified by IPAV R were
verified using real-time polymerase chain reaction (RT-PCR). Supplementation with shilajit for 14 weeks was not associated with any reported adverse effect within this period. At the higher dose (250mg bid), shilajit improved skin perfusion when compared to baseline or the placebo. Pathway analysis identified shilajit-inducible genes relevant to endothelial cell migration, growth of blood vessels, and ECM which were validated by quantitative RT-PCR analysis. This work demonstrates that oral shilajit supplementation induced genes relevant to endothelial cell migration, collagens and other extra-cellular matrix (ECM) proteins and growth of blood vessels, and improved skin micro perfusion in healthy adult women.

Dr. Sanni Raju, CEO of Natreon, stated, “This study adds to the growing clinical evidence for all the anti-aging benefits of PrimaVie® shilajit. Along with its earlier clinical studies, it’s proven that PrimaVie® shows highly significant upregulations of genes coding collagens (especially, COL1A1) and ECM proteins in skeletal muscle, such effect being synergistic with exercise. It also has shown to improve testosterone levels, mitochondrial function (increased ATP levels), endothelial function and cardiovascular health in healthy subjects.”

Reference: JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION

Click to read the full study.

For more information on PrimaVie® or Natreon’s full portfolio of ingredients, please email info@natreoninc.com or visit http://www.natreoninc.com

About PrimaVie:
PrimaVie® Biome Optimized Shilajit™ is sourced and purified from distinct biological ecosystems (biomes) and processed using sustainable green chemistry (water extraction), to provide optimal efficacy and bioactive diversity. This proprietary mineral extract has been studied in 10 randomized, double-blind, placebo-controlled human clinical trials. PrimaVie® is a powerful adaptogen standardized to achieve its proprietary composition consisting of urolithins (DBPs), fulvic acid and over 40 micro-minerals. PrimaVie® supports many health benefits such as boosting testosterone, strength, energy, and endurance levels, while also up-regulating the genes responsible for collagen synthesis. It has excellent applications in supplements, sports nutrition and healthy aging products. PrimaVie® is the only Non-GMO project verified, vegan, gluten free, and GRAS affirmed shilajit extract.

About Natreon:
Natreon is a leader in nutritional ingredient innovation, quality and research. Trusted by manufacturers for over 20 years, Natreon’s patented ingredients are derived from nature and founded on evidence-based Ayurveda. Committed to quality, its extracts are purified and standardized using proprietary process technology and controls that result in optimal levels of bioactive constituents. Natreon’s ingredients have been tested in multiple clinical studies (52 as of this date) and are GRAS-affirmed to ensure efficacy, safety and authenticity. Natreon brings storied knowledge and expertise in botanical cultivation and extraction, and its ingredients are sustainably sourced through an integrated supply chain to ensure quality and potency. Natreon has its global headquarters in New Jersey and a state-of-the-art R&D facility in Kolkata, India.

Contact:
Dr. Sanni Raju, CEO & Chairman or Bruce Brown, President
2-D Janine Place
New Brunswick, NJ 08901
Tel: 732-296-1080
E-mail: info@natreoninc.com

Read the full story at https://www.prweb.com/releases/new_clinical_trial_natreons_primavie_shilajit_ingredient_showed_results_of_improved_skin_health_in_adult_women/prweb16430376.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine technology :

1. HHHRA
2. HR Maximizer Annual Healthcare Provider & Clinical Staff Conference Announces Platinum Sponsor and Topics List
3. AskBio's Perspective on Pfizer's 1b Clinical Trial Results on Duchenne MD Gene Therapy
4. The Conference Forum Announces Disruptive Innovations in Clinical Trials Event (DPharm) 2019 Keynotes
5. ERT Showcases Scientific and Technological Expertise in Improving Clinical Research at DIA Annual Meeting
6. Remote Cardiac Monitor Data and Artificial Intelligence: Transforming Clinical Applications for Heart Patients
7. Dr. Kalyan Gaddam Announces The Results Of A Clinical Study For Relief For Patients With Cancer Cachexia
8. WBR Insights Study Finds Aromatherapy Gaining Traction for Clinical Patient Care
9. SoniVie Presents Clinical Trial Data Supporting the Safety and Efficacy of the TIVUS™ System in the Treatment of Pulmonary Arterial Hypertension
10. CISCRP’s Medical Heroes Appreciation 5K Run & Walk to Celebrate Clinical Study Volunteers
11. ActiGraph Partners with VivoSense to Enhance Secure Access to Regulated Sensor Data from Patients in Pharmaceutical Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2019)... ... July 23, 2019 , ... New research is finding ... A study published last year in the journal Drug and Alcohol Dependence ... now combining meth with their daily drug use. The researchers wrote, "Methamphetamine served as ...
(Date:7/23/2019)... ... ... Breathe Life , a provider of consumer-centric digital solutions for the insurance industry, ... joined its board of directors. Mr. Hill, a serial entrepreneur, operator, and investor brings ... Life board at a time of rapid growth. , Breathe Life is focused on ...
(Date:7/23/2019)... ... July 23, 2019 , ... Miriam “Mimi” Boublik has been elected ... at its roots in New York City. , Boublik has been a member ... she founded the Jericho Associate Board (now the Young Professionals Council) to engage New ...
Breaking Medicine Technology:
(Date:7/17/2019)... ... July 17, 2019 , ... In order to achieve the mission, the ... could occur, from the accident scene, to the moment the teeth are replanted and ... for treatment. , They identified seven points, so called links in a chain, along ...
(Date:7/17/2019)... ... July 17, 2019 , ... Dynamic Healthcare Systems, ... Advantage, Medicaid, and Marketplace programs is pleased to announce the introduction of an ... (EHR) integration at the point of care to providers and provider groups ...
(Date:7/17/2019)... ... ... It took just several small incisions by St. Luke's University Health Network ... under Amber Walck’s scalp, and suddenly her two-year agony with migraines was history. ... began without warning. About 39 million Americans suffer from migraines that range from ...
(Date:7/17/2019)... ... July 17, 2019 , ... Athena ... for human services providers worldwide, has been awarded a California Multiple Award Schedules ... procurement process for state and local government agencies in California by designating pre-approved ...
(Date:7/17/2019)... ... ... People considering surrogacy usually have an altruistic desire to help others who ... addition to creating a family, they have the opportunity to develop a very deep ... electing to have a child through the surrogacy process. An interview with an Intended ...
Breaking Medicine News(10 mins):